Kuala lumpur: Malaysia and Singapore are further strengthening their strategic health partnership, working together to address non-communicable diseases (NCDs), coordinate Nutri-Grade food labelling policies, and explore opportunities to expand medical tourism. Health Minister Datuk Seri Dr Dzulkefly Ahmad announced the agreement, which was formalized through a Memorandum of Understanding (MoU) signed during a meeting with his Singaporean counterpart, Ong Ye Kung.
According to BERNAMA News Agency, the MoU signifies the high level of trust and commitment both nations share for the well-being of their citizens. Key agendas discussed include the alignment of the Nutri-Grade food labelling policy, a proactive step aimed at combating NCDs across the region. Dzulkefly emphasized the importance of this agreement in strengthening ties and fostering a healthier populace.
Dzulkefly also highlighted Malaysia's support for the Medical Device Regulatory Reliance Programme, which is anticipated to expedite access to high-quality and innovative medical technology in the regional market. Both countries are exploring the potential expansion of cross-border health tourism, including facilitating patient referrals from Singapore to private healthcare facilities in Johor and expanding Medisave insurance coverage. Such initiatives are expected to enhance healthcare access and stimulate economic benefits, particularly in Malaysia's southern region.
The Minister underscored the significance of Malaysia-Singapore cooperation in addressing complex public health challenges, aiming to build a sustainable, resilient, and human-centred regional health system. He reaffirmed Malaysia's commitment to advancing health diplomacy and regional cooperation rooted in mutual respect and shared prosperity.
In a separate statement, Dzulkefly addressed the role of AI in healthcare, emphasizing that it should be seen not just as a technological advancement but as a practice rooted in public trust and strong governance. This was discussed during a high-level meeting on AI hosted by the Government of Portugal in Geneva. Dzulkefly stressed the importance of secure data management and interoperable digital health systems to protect patient information.
Malaysia is currently demonstrating AI's effectiveness in healthcare through AI-powered lung screenings at public health clinics and field programs nationwide. To date, 9,174 patients have been screened, with significant findings including abnormal chest X-rays, lung nodules, high-risk cancer cases, and suspected tuberculosis (TB) cases. These early detections facilitate prompt referrals and treatment, potentially saving lives.
Despite advancements in AI technology, Dzulkefly emphasized that medical practitioners and frontline healthcare workers remain central to clinical decisions and treatment. He assured that AI is intended to empower and augment healthcare professionals' abilities, not replace them. Dzulkefly concluded by reaffirming Malaysia's commitment to responsibly guiding health technology development, ensuring a sustainable healthcare system that upholds human values.